Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(3):183-186; doi:10.1093/jnci/djk057
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Touw, I. P.
Right arrow Articles by Bontenbal, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touw, I. P.
Right arrow Articles by Bontenbal, M.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

EDITORIAL

Granulocyte Colony-Stimulating Factor: Key (F)actor or Innocent Bystander in the Development of Secondary Myeloid Malignancy?

Ivo P. Touw, Marijke Bontenbal

Affiliations of authors: Departments of Hematology (IPT) and Medical Oncology (MB), Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands

Correspondence to: Ivo P. Touw, PhD, Department of Hematology, Erasmus University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands (e-mail: i.touw@erasmusmc.nl).

The first 150 words of the full text of this article appear below.

Granulocyte colony-stimulating factor (G-CSF), the major cytokine involved in the control of neutrophil production, is used in the clinic for treatment of congenital and acquired neutropenias and to reduce febrile neutropenia before or during courses of intensive cytoreductive therapy. In addition, healthy stem cell donors are treated with G-CSF for mobilization of hematopoietic stem cells in the peripheral blood. Recent studies have uncovered novel roles for G-CSF in myocardial regeneration following cardiac infarction (1–3) and in ameliorating programmed cell death in neuronal cells caused by acute ischemic stroke, thereby reducing the volume of the brain infarct (4). Thus, it may be anticipated that the therapeutic application of G-CSF will increase considerably in the near future, making careful and timely risk assessment of vital importance.

In this issue of the Journal, Hershman et al. (5) report a twofold increased risk of secondary myelodysplasia . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant Chemotherapy
Dawn Hershman, Alfred I. Neugut, Judith S. Jacobson, Jian Wang, Wei-Yann Tsai, Russell McBride, Charles L. Bennett, and Victor R. Grann
J Natl Cancer Inst 2007 99: 196-205. [Abstract] [Full Text] [PDF]

Press Release: Growth Factors Commonly Given With Chemotherapy Associated With Increased Risk of Blood Diseases
Andrea Widener
J Natl Cancer Inst 2007 99: 181. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 The OncologistHome page
H. Ozer, B. Mirtsching, M. Rader, S. Luedke, S. J. Noga, B. Ding, and L. Dreiling
In Reply
Oncologist, December 1, 2007; 12(12): 1465 - 1466.
[Full Text] [PDF]

Home page
 JCOHome page
D. A. Patt, Z. Duan, S. Fang, G. N. Hortobagyi, and S. H. Giordano
Acute Myeloid Leukemia After Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk
J. Clin. Oncol., September 1, 2007; 25(25): 3871 - 3876.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. L. Warren and M. L. Brown
Re: Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant Chemotherapy
J Natl Cancer Inst, July 4, 2007; 99(13): 1050 - 1050.
[Full Text] [PDF]